Key statistics
On Monday, Xeris Biopharma Holdings Inc (XERS:NSQ) closed at 6.02, 67.69% above the 52 week low of 3.59 set on Mar 04, 2025.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
| Open | 7.08 |
|---|---|
| High | 7.12 |
| Low | 5.91 |
| Bid | 5.85 |
| Offer | 6.33 |
| Previous close | 6.12 |
| Average volume | 2.69m |
|---|---|
| Shares outstanding | 165.92m |
| Free float | 159.50m |
| P/E (TTM) | -- |
| Market cap | 1.02bn USD |
| EPS (TTM) | -0.1033 USD |
Data delayed at least 15 minutes, as of Mar 02 2026 21:00 GMT.
More ▼
- Xeris Biopharma Reports Record Performance for Fourth Quarter and Full Year 2025 and Provides Full Year 2026 Guidance
- Xeris Biopharma Subsidiaries File Recorlev® Patent Infringement Lawsuit
- Xeris Biopharma to Report Full Year 2025 Financial Results and Provide Full Year 2026 Guidance on March 2, 2026
- Xeris Expects to Deliver Record Fourth Quarter and Full-Year 2025 Total Revenue
- Xeris Pharmaceuticals Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
More ▼
